Company Information
- Type:
- Company
- Country:
- Argentina
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Delisted
- Reason for Delisting:
- Expelled due to failure to communicate progress
- Participant Since
- 21 July 2004
- Next Communication on Progress (COP) due on:
- 05 March 2015
Financial Information
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 05-Mar-2014 | Communication on Progress | Active |
| 28-Feb-2013 | Communication on Progress | Active |
| 28-Feb-2012 | Communication on Progress | Active |
| 18-Feb-2011 | 2011 Communication on Progress | Active |
| 22-Feb-2010 | 2010 Communication on Progress | Not applicable |
| 23-Feb-2009 | Novartis Argentina - Communication on progress - 2008 | Not applicable |
| 25-Feb-2008 | Novartis Argentina - Communication on Progress - 2007 | Not applicable |
| 26-Feb-2007 | Responsabilidad social: integrada a nuestra estrategia y clave para nuestro éxi-to | Not applicable |
| 18-Jul-2006 | Etica y desempeño social integrados al núcleo de la estrategia empresarial - 2005 | Not applicable |
| 20-May-2005 | Ética y desempeño social integrados al núcleo de la estrategia empresarial: Argentina | Not applicable |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.